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Abstract: Human coronavirus OC43 (HCoV-OC43) is one of five currently circulating 
human coronaviruses responsible for respiratory infections. Like all coronaviruses, it is 
characterized by its genome’s high plasticity. The objectives of the current study were to 
detect genetically distinct genotypes and eventually recombinant genotypes in samples 
collected in Lower Normandy between 2001 and 2013. To this end, we sequenced 
complete nsp12, S, and N genes of 15 molecular isolates of HCoV-OC43 from clinical 
samples and compared them to available data from the USA, Belgium, and Hong-Kong.  
A new cluster E was invariably detected from nsp12, S, and N data while the analysis of 
nsp12 and N genes revealed the existence of new F and G clusters respectively.  
The association of these different clusters of genes in our specimens led to the description 
of thirteen genetically distinct genotypes, among which eight recombinant viruses were 
discovered. Identification of these recombinant viruses, together with temporal analysis 
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and tMRCA estimation, provides important information for understanding the dynamics of 
the evolution of these epidemic coronaviruses. 
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1. Introduction 
Coronaviruses belong to the Coronaviridae family in Nidovirales order [1]. This order comprises 
the largest enveloped single-strand RNA viruses, and includes three other families; Arterividae, 
Roniviridae, and the most recently described Mesoniviridae [2]. Coronaviruses are divided into four 
genera named Alpha-, Beta-, Delta-, and Gammacoronavirus, based on the phylogenetic distance of 
highly conserved domains [3–5]. Alphacoronaviruses are divided into two subgroups or clades, A and B 
or 1 and 2, and betacoronaviruses are divided into four subgroups or clades, A to D or 1 to 4 [6,7]. 
Coronaviruses infect a wide range of avian or mammalian species, and are responsible for enteric or 
respiratory infections [8–10]. Six human coronaviruses (HCoVs) have been identified of which four 
are in circulation: HCoV-229E, HCoV-NL63 (genus Alphacoronavirus), and HCoV-OC43 and  
HCoV-HKU1 (genus Betacoronavirus clade A). These four viruses are responsible for mild upper-respiratory 
tract infections, yet cause more severe respiratory pathologies in infants, immunocompromised patients and 
elderly people [11–22]. The other two human coronaviruses, Severe Acute Respiratory Syndrome 
coronavirus (SARS-CoV) and Middle-East Respiratory Syndrome coronavirus (MERS-CoV), 
belonging to Betacoronavirus genus, clades B and C respectively, cause severe respiratory pathologies. 
SARS-CoV circulated in 2002–2003 and caused a global outbreak with more than 8000 cases, and 
produced a rate of fatal cases of nearly 10%; and MERS-CoV emerged in 2012 in the Middle-East, 
causing severe pneumonia similar to that from SARS [23–25]. To date, 961 laboratory confirmed cases 
of MERS-CoV infection, including 418 fatal cases, have been reported [26]. 
The first isolation of HCoV-OC43 from a nasopharyngeal wash was reported in a publication in 
1967 [13]. In 2004 and 2005 respectively, St-Jean et al. and Vijgen et al. published the first complete 
genome sequence of HCoV-OC43 [27,28]. The genome of HCoV-OC43 consists of a positive sense, 
single-stranded RNA molecule, which is 30,738 bases in length, encoding 11 ORFs. The first two 
ORFs (1a and 1b) starting from the 5' end of the molecule account for approximately two-thirds of the 
genome. The last third towards the 3' end containing genes coding the hemagglutinin esterase (HE), the 
spike glycoprotein (S), the envelop protein (E), the matrix glycoprotein (M), and the nucleocapsid 
phosphoprotein (N). The mechanism of replication of HCoV-OC43 uses a low fidelity RNA dependent 
RNA polymerase (RdRp) characterized by a mutation rate of 10−3 to 10−4 mutation/nucleotide/round of 
replication [29,30]. The replication of coronavirus genomes requires a step during which a set of 
subgenomic RNAs is generated. This mechanism contributes to promoting homologous recombination 
events [31]. Due to its genomic plasticity, coronaviruses are characterized by a high potential of 
evolution, adaptation, and interspecies jumping [7]. Coronaviruses are also characterized by their 
interspecies and intraspecies variability. This study is focused on the latter. 
In 2006, Vabret et al. observed the co-circulation of genetic variants inside the species HCoV-OC43 
by analysing the partial S gene (nt 23,449 to 26,332, reference to HCoV-OC43 ATCC-VR759 
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AY391777), coding for the glomerular part of the S protein (sub-unit S1) of 7 HCoV-OC43s from 
clinical samples collected in 2003 at the University Hospital of Caen. They observed four genetically 
distinct subgroups. One of the subgroups constitutes an outlier group located between HCoV-OC43 
and Bovine coronavirus (BCoV), containing a 12-nucleotide deletion in common with BCoV but not 
with other HCoV-OC43s [32]. More recently, four genetically distinct HCoV-OC43 genotypes have 
been identified from respiratory specimens sampled at the Public Hospital of China over a 7-year 
period (2004 to 2011) [33]. In this study, Lau et al. based their genotype definition upon the complete 
sequence of nsp12, S and N genes [33]. Genotype A contains the prototype VR759 strain isolated in 
1967. Genotypes B and C are two naturally circulating HCoV-OC43s. Genotype D is a recombinant 
virus of genotypes B and C, obtained from a specimen from 2004 [33]. Based on a bootscan analysis 
of the complete genome of the 3 HCoV-OC43s belonging to the circulating genotypes B, C, and D, it 
was assumed that a hot spot was likely located between the nsp12 and S genes, more precisely at the 
nsp12/nsp13 junction. Our objective was to investigate the presence, the temporal distribution and the 
recombination patterns of HCoV-OC43 in Lower Normandy over 13 years (2001 to 2013), using the 
methodology and the HCoV-OC43 genotype definition elaborated by Lau et al. in 2011 [33].  
This study focuses on the sequences of the nsp12, S, and N genes of 15 HCoV-OC43s detected in 
respiratory specimens sampled from 2001 to 2013. 
2. Results 
2.1. Sequencing of nsp12, S and N Genes 
Of the 15 HCoV-OC43s and the prototype strain VR759, six, eight, and three overlapping 
sequences were obtained for the nsp12, S, and N genes, respectively. After assembly, these overlapping 
fragments encompassed the full nsp12, S, and N genes. In this study, all HCoV-OC43s including the 
VR759 prototype strain are associated with three accession numbers in GenBank, for nsp12, S, and N 
genes (Table 1). The sequences of HCoV-OC43s were named according to the following nomenclature: 
Virus/FRA-EPI/location of sampling/year of sampling/specimen number. EPI is an abbreviation for 
EPICOREM consortium. For the prototype strain, the specimen number is replaced by VR759. 
Table 1. GenBank accession numbers associated with the sequences used in this study. 
Name of Sequences 
Accession Number 
nsp12 S N 
HCoV-OC43/FRA_EPI/Caen/1967/VR759 KF963213 KF963229 KF963245 
HCoV-OC43/FRA_EPI/Caen/2001/01 KF963214 KF963230 KF963246 
HCoV-OC43/FRA_EPI/Caen/2001/02 KF963215 KF963231 KF963247 
HCoV-OC43/FRA_EPI/Caen/2002/03 KF963216 KF963232 KF963248 
HCoV-OC43/FRA_EPI/Caen/2002/04 KF963217 KF963233 KF963249 
HCoV-OC43/FRA_EPI/Caen/2003/05 KF963218 KF963234 KF963250 
HCoV-OC43/FRA_EPI/Caen/2004/06 KF963219 KF963235 KF963251 
HCoV-OC43/FRA_EPI/Caen/2005/07 KF963220 KF963236 KF963252 
HCoV-OC43/FRA_EPI/Caen/2006/08 KF963221 KF963237 KF963253 
HCoV-OC43/FRA_EPI/Caen/2007/09 KF963222 KF963238 KF963254 
HCoV-OC43/FRA_EPI/Caen/2008/10 KF963223 KF963239 KF963255 
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Table 1. Cont. 
Name of Sequences 
Accession Number 
nsp12 S N 
HCoV-OC43/FRA_EPI/Caen/2009/11 KF963224 KF963240 KF963256 
HCoV-OC43/FRA_EPI/Caen/2010/12 KF963225 KF963241 KF963257 
HCoV-OC43/FRA_EPI/Caen/2011/13 KF963226 KF963242 KF963258 
HCoV-OC43/FRA_EPI/Caen/2012/14 KF963227 KF963243 KF963259 
HCoV-OC43/FRA_EPI/Caen/2013/15 KF963228 KF963244 KF963260 
 
full genome 
OC43/human/USA/971-5/1997 KF530099 
OC43/human/USA/965-6/1996 KF530098 
OC43/human/USA/832-27/1983 KF530093 
OC43/human/USA/008-5/2000 KF530092 
OC43/human/USA/911-58/1991 KF530091 
OC43/human/USA/931-85/1993 KF530090 
OC43/human/USA/901-54/1990 KF530088 
OC43/human/USA/872-5/1987 KF530086 
OC43/human/USA/951-18/1995 KF530084 
OC43/human/USA/8912-37/1989 KF530073 
OC43/human/USA/925-1/1992 KF530071 
OC43/human/USA/007-11/2000 KF530068 
OC43/human/USA/953-23/1995 KF530062 
HK04_01 JN129834 
HK04_02 JN129835 
19572 Belgium 2004 AY903460 
87309 Belgium 2003 AY903459 
HCoV-OC43 VR759 [28] NC_005147 
HCoV-OC43 VR759 [34] AY391777 
BCoV Mebus U00735 
BCoV Kakewaga AB354579 
BCoV Quebec AF220295 
2.2. Phylogenetic Analysis of nsp12, S, and N Genes 
The phylogenetic analysis was conducted by comparing the topology of the three phylogenetic trees 
obtained from the nsp12, S, and N genes. Figure 1 shows the three trees obtained by the neighbor 
joining method [35]. On each tree, five to six clusters were observed, including an outlier group 
compounded with the three BCoVs sequences Mebus, Kakegawa, and Quebec that root HCoV-OC43 
sequences [36–38]. The clustering is supported with high bootstrap values. We used part of the 
nomenclature of genotypes proposed by Lau et al. in 2011 [33]. These authors described the genotypes 
A, B, C, and D from nsp12, S and N genes. We used this nomenclature to name each genotype using 
three letters corresponding to clusters in which the different sequences are located in nsp12, S, and N 
trees, respectively. Following this nomenclature, genotype D is a recombinant genotype B/C/C.  
The three previously described clusters—A, B, and C—are observed in our three gene trees in addition 
to a newly described cluster E. The nsp12 tree depicts a new cluster we named “F” that roots all other 
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HCoV-OC43s. According to the N gene, a sixth cluster we named “G” separates from cluster E and 
roots clusters A, B, and C. Among the set of sequences obtained from the 16 HCoV-OC43s of our 
study, three are distributed in two non-recombinant genotypes as follows: the VR759 sequence belongs 
to the genotype AAA; HCoV-OC43/FRA-EPI/Caen/2003/05 and HCoV-OC43/FRA-EPI/Caen/2006/08 
belong to genotype BBB. The 13 other sets of sequences are allocated among six recombinant 
genotypes as follows: five genotypes BCC, defined as genotype D by Lau et al.; two genotypes CEE, 
three genotypes CBE, one genotype BCG, one genotype CCE, and one genotype CEB. Among the  
14 American sets of sequences, seven are distributed into two non-recombinant genotypes as follows: 
one CCC and six EEE. The seven other sets of sequences are distributed among four recombinant 
genotypes as follows: three genotypes CCA, two genotypes FCB, one genotype CCB, and one 
genotype CEE. Among the two sets of sequences from Hong-Kong, one is a non-recombinant 
genotype CCC and the other is a recombinant genotype BCC. Among the two HCoV-OC43s from 
Belgium, one is a non-recombinant genotype BBB and the other is a recombinant genotype BCC. 
Finally, the two last sequences of HCoV-OC43 VR759 (accession number: AY391777 and 
NC005147) belong to the non-recombinant genotype AAA [28,39]. The results of the phylogenetic 
analysis are summarized in Table 2. 
2.3. Insights in the Evolutionary History 
The two alignments constructed from the 39 dated sequences of S and N genes have been used to 
set up a molecular clock calibration in order to estimate the date of emergence of mean clusters.  
Figure 2 shows Bayesian trees inferred from the alignments of S and N genes. The dates of emergence 
of the clusters and the corresponding 95% Highest Posterior Density (95% HPD) are indicated.  
Based on the sequence data of the S gene, the tMRCA of BCoV and HCoV-OC43 is estimated in 
1885, with a 95% HPD from 1858 to 1907. For the HCoV-OC43, cluster E is predicted to have 
emerged in 1943 (95% HPD 1933 to 1952), and genotype A is estimated to have emerged in 1951 
(95% HPD, 1943 to 1959). Genotypes B and C are predicted to have emerged from their tMRCA in 
1982 (95% HPD, 1980 to 1983). The molecular clock conducted from sequence data of N gene allows 
us to estimate the tRMCA of BCoV and HCoV-OC43 in 1879 (95% HPD, 1822 to 1923). Genotypes E 
and A are predicted to have emerged in 1932 (95% HPD, 1904 to 1952) and 1957 (95% HPD, 1950 to 
1972), respectively. Genotypes B and C are predicted to have emerged from their tMRCA in 1984 
(95% HPD, 1976 to 1991). 
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Figure 1. Phylogenetic analysis of the complete nsp12, S, and N genes of the 36 HCoV-OC43 strains and 3 BCoV strains. The phylogenetic 
trees were constructed by the neighbor joining method [35]. Bootstrap values were calculated from 1000 replicates. Bootstrap values over 
70% are shown [40]. The evolutionary distances were computed using the Kimura 2-parameter method (kimura) and units are the number of 
base substitutions per site. Evolutionary analyses were conducted in MEGA, version 6.06. [41]. Blue triangle, isolates from Caen; red circle, 
isolates from USA; green circle, isolates from Hong-Kong; black diamond, isolates from Belgium; purple square, ATCC-VR759 strains, 
empty black square, BCoV strains. 
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Figure 2. Results of Bayesian analysis based on S and N gene sequence data. Inferences were calculated with the one parametric coalescent 
model with a constant size, under the TN93+G substitution parameter, using the BEAST package (version 1.8.2) [42]. The length of MCMC 
was fixed at 108 states for S and N genes. The dates of emergence of mean clusters are indicated, associated with the 95% HPD. 
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Table 2. Results of phylogenetic analysis of complete nsp12, S and N genes. * Genotype D, 
according to the definition from Lau et al. [33]. 
Sequences nsp12 S N Genotype 
France 
HCoV-OC43/FRA_EPI/Caen/2001/01 C E B CEB 
HCoV-OC43/FRA_EPI/Caen/2001/02 C C E CCE 
HCoV-OC43/FRA_EPI/Caen/2002/03 B C C BCC * 
HCoV-OC43/FRA_EPI/Caen/2002/04 C E E CEE 
HCoV-OC43/FRA_EPI/Caen/2003/05 B B B BBB 
HCoV-OC43/FRA_EPI/Caen/2004/06 B C C BCC * 
HCoV-OC43/FRA_EPI/Caen/2005/07 C E E CEE 
HCoV-OC43/FRA_EPI/Caen/2006/08 B B B BBB 
HCoV-OC43/FRA_EPI/Caen/2007/09 C B E CBE 
HCoV-OC43/FRA_EPI/Caen/2008/10 C B E CBE 
HCoV-OC43/FRA_EPI/Caen/2009/11 B C C BCC * 
HCoV-OC43/FRA_EPI/Caen/2010/12 C B E CBE 
HCoV-OC43/FRA_EPI/Caen/2011/13 B C C BCC * 
HCoV-OC43/FRA_EPI/Caen/2012/14 B C G BCG 
HCoV-OC43/FRA_EPI/Caen/2013/15 B C C BCC * 
USA 
OC43/human/USA/832-27/1983 E E E EEE 
OC43/human/USA/851-15/1985 E E E EEE 
OC43/human/USA/872-5/1987 E E E EEE 
OC43/human/USA/8912-37/1989 E E E EEE 
OC43/human/USA/901-54/1990 C C A CCA 
OC43/human/USA/911-58/1991 C C A CCA 
OC43/human/USA/925-1/1992 C C A CCA 
OC43/human/USA/931-85/1993 E E E EEE 
OC43/human/USA/953-23/1995 E E E EEE 
OC43/human/USA/951-18/1995 F C B FCB 
OC43/human/USA/965-6/1996 F C B FCB 
OC43/human/USA/971-5/1997 C C C CCC 
OC43/human/USA/007-11/2000 C C B CCB 
OC43/human/USA/008-5/2000 C E E CEE 
Hong-Kong 
HK04_01 C C C CCC 
HK04_02 B C C BCC * 
Belgium 
BE03 B B B BBB 
BEO4 B C C BCC * 
VR759 
    
HCoV-OC43 (AY391777) A A A AAA 
HCoV-OC43 VR759 (NC005147) A A A AAA 
HCoV-OC43/FRA_EPI/Caen/1967/VR759 A A A AAA 
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3. Discussion 
The 4 HCoVs—OC43, 229E, NL63, and HKU1—belong to the viral molecular panel tested during 
the virological routine diagnostics of acute respiratory infections in humans. Among these four circulating 
HCoVs, OC43 and NL63 seem to show the greatest prevalence and incidence. These viruses also 
proved to be the viruses encountered at the earliest age of childhood [43]. These HCoVs circulate 
widely in epidemic form in the general population, causing infections that are most often benign. 
Infants, immunosuppressed patients, and very elderly patients may however develop very severe 
pathologies. These four circulating HCoVs must be distinguished from the emerging HCoVs,  
SARS-CoV, and MERS-CoV, causes of much graver and potentially fatal respiratory pathologies. 
Control of the latter HCoVs requires the implementation of international health measures [44–46]. 
The evolutionary potential of coronaviruses brings into play point mutations and recombination 
events. Such genetic diversity generated in this way may have an impact on the performance of 
molecular detection techniques used in the virological diagnostic process. The study of intra-specific 
diversity is thus useful in the monitoring of means of detection. Specifically, it allows for the detection 
of new circulating variants, and provides information about the evolutionary dynamics of the family of 
respiratory viruses being monitored, with special attention given to coronaviruses. Our study focuses 
solely on the HCoV-OC43. 
The first analyses of the HCoV-OC43 S gene were conducted in 2005 and revealed a potential 
spatial and temporal distribution of genetic clusters [34]. In 2011, S. Lau and his colleagues were the 
first to propose a genotypic classification of HCoV-OC43 from the complete sequencing of three 
genes: Nsp12 (RdRp), S (spike), and N (nucleocapsid). Four genotypes—A, B, C, and D—were 
identified: genotype A corresponds to the sequences of the HCoV-OC43 prototype strain VR759, 
adapted to culture cell line HRT-18 (human adenocarsinoma rectal) or RD (rhabdomyosarcoma); 
genotypes B and C correspond to contemporary circulating strains, and genotype D is described as a 
recombinant B/C virus. This study was performed on 29 HCoV-OC43s detected in respiratory samples 
collected in Hong Kong over a period of 7 years (2004 to 2011), in a non-homogenous temporal 
distribution. More precisely, the majority of these samples (18 of 29) were collected in 2004, and the 
others (11 of 29) fall between 2005 and 2011 [33]. Our study defines the genotype of 15 HCoV-OC43s 
detected from upper respiratory samples frozen at −80 °C, collected over a period of 13 years from 
2001 to 2013 at the rate of one to two samples per year. The 15 HCoV-OC43s were detected in patients 
hospitalized in our university hospital. Of these 15 patients, 10 were male and five were female, at ages 
from 4 months to 67 years. The symptomatology proved variable (Table 3). The infections were 
essentially located in upper and lower respiratory airways. The presence of associated gastrointestinal 
symptoms in some patients should be noted. The prototype strain HCoV-OC43 ATCC VR759, grown 
on cell line HRT-18, was used as a control, allowing for the validation of the methodology used by 
Lau et al. [33]. This methodology had to be adapted since some of the primers published by the 
authors did not allow for amplification of all the HCoV-OC43s. 
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Table 3. Clinical features of the 15 french patients. a Mo., month; yr., year; d., days. b M, 
male; F, female. c Na, not available. 
Specimen 
Age at Time 
of Sampling a 
Date If Sampling 
(Day/Mo/Year) 
Gender b 
Duration of 
Hospitalization c 
Final Diagnosis 
Caen/2001/01 3 mo. 02/20/2001 M na na 
Caen/2001/02 3 yr. 02/07/2011 M 4 d. gastroenteritis 
Caen/2002/03 5 mo. 03/12/2002 M 15 d. 
nasoparyngitis, seromucous  
bilateral otitis 
Caen/2002/04 4 mo. 02/21/2002 M na na 
Caen/2003/05 1 yr. 03/17/2003 M na na 
Caen/2004/06 1 yr. 02/20/2004 F 4 d. gastroenteritis 
Caen/2005/07 2 yr. 02/07/2005 F 4 d. gastroenteritis, acute otitis media 
Caen/2006/08 11 mo. 04/12/2006 M na na 
Caen/2007/09 6 mo. 06/16/2007 M na na 
Caen/2008/10 3 yr. 01/17/2008 M 5 d. acute etmoidis 
Caen/2009/11 3 mo. 11/02/2009 M 3 d. bronchitis 
Caen/2010/12 1 yr. 12/17/2010 M na bronchitis 
Caen/2011/13 4 mo. 11/20/2010 M na na 
Caen/2012/14 67 yr. 03/30/2012 M na confusion 
Caen/2013/15 53 yr. 03/18/2013 F na Upper respiratory infection 
The alignments of complete sequences of three genes—nsp12, S, and N—of the 15 HCoV-OC43s 
used in this study were generated and enriched by the addition of the corresponding sequences of 
several complete HCoV-OC43 genomes available in GenBank: two prototype sequences of  
HCoV-OC43s VR759 published by Vijgen et al. in 2005 [28]; two HCoV-OC43s from 2004 reported 
by Lau et al. in 2011 (HK04_01, HK04_02) [33]; and two HCoV-OC43s described in Belgium in 2003 
and 2004 (Belgium 03 and Belgium 04 respectively) [34]. This data set was completed at the end of 
2013 with the publication of 41 complete HCoV-OC43 sequences by Town et al. in GenBank.  
These sequences correspond to 41 HCoV-OC43s identified in the USA (Maryland) between 1983 and 
2000. Of these 41 sequences, we selected 14 that reflect the genetic diversity and temporal distribution 
of the whole, and we introduced them into the alignment. In the end, three respective alignments of 
complete genes—nsp12, S, and N—of 36 HCoV-OC43s identified in three different regions of the 
world (Hong Kong, Europe, and the USA) over a period of 30 years (from 1983 to 2013) were 
generated and analyzed. They served as the basis for the construction of phylogenetic trees. Within the 
three phylogenetic trees—nsp12, S, and N—we identified six different clusters named A, B, C, E, F, 
and G. A comparative study of the topology of phylogenetic trees corresponding to several genes of 
the same virus is often used in phylogeny to define recombinant viruses [33,47,48]. We thus compared 
the topology of nsp12, S, and N trees by observing the contextual position of the corresponding 
sequences of the same HCoV-OC43 molecular isolate. The complexity of the results of our analysis 
led us to establish a nomenclature allowing for the simplest expression of the genotypes: each 
genotype is expressed in the form of a three-letter code, linking each one to the member cluster of the 
different nsp12, S, and N sequences. From here, we defined 13 different genotypes, of which four were  
non-recombinant (AAA, BBB, CCC, and EEE). The nine remaining genotypes correspond to different 
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recombinant genotypes (Table 2). Among the 36 HCoV-OC43 sequences examined in this study,  
14 HCoV-OC43s of so-called non-recombinant genotypes were found: three HCoV-OC43s of 
genotype AAA corresponding to prototype strains VR759; three HCoV-OC43s of genotype BBB 
(origin, France 2003 and 2006, and Belgium 2003); two HCoV-OC43s of genotype CCC (origin, USA 
1997 and Hong Kong 2004); and lastly, six HCoV-OC43s of genotype EEE, all originating in the 
USA, and having circulated from 1983 to 1995. The foremost important point to underline is that these 
results suggest a high level of recombination among circulating HCoV-OC43 epidemic strains.  
The limited number of sequences studied in time and space does not allow for conclusive evidence of a 
possible temporal and spatial distribution of different genotypes HCoV-OC43. However, it should be 
noted that the E cluster has not yet been described. In the present study, it is identified only in  
HCoV-OC43 sequences from the USA and France and data suggest that it has been circulating since 
the 1940s after being the first known group to differentiate from BCoV. 
The analysis of alignments shows that cluster E is characterized by a deletion of 12 nucleotides in 
the S gene, more precisely in the S1 gene that codes the glomerular part of the S protein (position 
24,091–24,102, GenBank accession number NC_005147). This deletion of 12 nucleotides in the 
coding phase results in a deletion of 4 amino acids, TQDG, in the corresponding protein sequence. 
This deletion was also present in the bovine coronavirus strains used in the alignment, as shown in 
Figure 3. The analysis of 105 S1 BCoV sequences available in GenBank shows that this deletion is 
expressed in all BCoVs, and described in bovine coronaviruses associated with both enteric and 
respiratory tropisms. This deletion is therefore not a specific marker of viral tropism. It is located in the 
lectin domain of the S1 protein of BCoV, and is involved in the attachment of the virus to the cellular 
receptor, identified as a derivative of neuraminic acid (N-acetyl-9-O-acetylneuraminic acid or 
Neu5,9Ac2). No protein receptor has yet been described for the BCoV or, more broadly, for 
Betacoronavirus bovine-like clade A. We analyzed all the sequences of this S1 HCoV-OC43 region 
available in GenBank, for a total of 108 sequences, and the deletion of 12 nucleotides is found in only 
27 of them. Of these 27 sequences, 19 correspond to HCoV-OC43s detected in respiratory samples 
from the USA and sequenced by Town et al. Four correspond to HCoV-OC43s detected in France 
(three in the current study, and one published by our team in 2006); two correspond to HCoV-OC43 
sequences deposited by Browlin et al. under patent in the United Kingdom (EP2182066 and 
WO2004011651), and finally, the remaining two correspond to HCoV-OC43s adapted to Vero cells 
and MDCK I, published in 1996 by F. Künkel and Herrler G [49]. The HCoV-OC43 E cluster is 
phylogenetically close to the BCoV cluster, and the presence of the genetic marker common to these 
two clusters provides an argument supporting the hypothesis put forth by Vijgen in 2006 that would 
identify a crossing of the species barrier occurring from cattle to human [39]. A molecular clock 
analysis was inferred using the BEAST software version 1.8.1 (http://beast.bio.ed.ac.uk) based on 
sequence alignments of S and N genes. Sequences of the nsp12 gene were not used because they were 
uninformative due to the low variability of this gene. Results were compared with those previously 
obtained by Vijgen from 20 Betacoronavirus clade A sequences (nine BCoVs, three PHEVs, and eight 
HCoV-OC43s). It should be noted that eight sets of HCoV-OC43 sequences used in the analysis of 
Vijgen et al. in 2006 were obtained from samples collected over a very short period between 2003 and 
2004 [39]. 
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Figure 3. Alignement of some of the S genes sequences. This aligment was made using 
Bioedit Software version 7.2.5 (Ibis Biosciences, Carlsbad, CA, USA). 
In 2013, Wertheim et al. demonstrated that a strong purifying selection could lead to the 
underestimation of the evolutionary rate of coronaviruses. In this study, the authors proposed an 
alternative theory of origin for all coronaviruses. They estimate the tMRCA of coronaviruses infecting 
mammalian species (Alpha- and Betacoronavirus genus) and avian species (Gamma- and 
Deltacoronavirus genus) at about 293 million years, as opposed to 10,000 years as previously 
estimated [5]. These authors found a general agreement in the inferred branch lengths between 
evolutionary models for the shorter branches (inferior to 0.05 substitution per site). As expected in  
the phylogeny of two species of the same coronavirus genus involved in a relatively recent zoonotic 
transmission event, all the branches of neighbor joining and Bayesian trees were shorter than  
0.03 substitutions per site, as shown in Figures 1 and 2. It can be speculated that the phylogenetic 
analyses presented in this study did not underestimate the date of emergence of the different clusters 
nor the estimation of tMRCA for HCoV-OC43 and BCoV. The molecular clock analysis indicated that  
HCoV-OC43 and BCoV strains have emerged from their tMRCA around 1890 (1859–1952), which 
was consistent with the data published by Vijgen et al. in 2006 [39]. The emergence of cluster E, 
characterized by a TQGD amino acid deletion, is estimated at around 1944 (1942–1968), and would 
have occurred at the same time as that of cluster A, in the 1942–1958 time range. The cluster A 
includes the first HCoV-OC43 strain identified in 1967 from a respiratory sample [13]. The B and C 
clusters would have circulated later, since the 1980s. The molecular clock results therefore suggest 
that, since their emergence in the late nineteenth century, the evolution of circulating HCoV-OC43 
epidemic strains would have been marked by the occurrence of an insertion of four amino acids, 
TQDG, in the N-terminal region of the S1 attachment protein, as opposed to the occurrence of the 
deletion of these four amino acids. The pursuit of this study should lead to a means of determining the 
functional impact of this insertion, especially with regard to tropism and the clinical expression of 
infection by HCoV-OC43. Note that the frequent presence of gastrointestinal symptoms in the clinical 
landscape of HCoV-OC43 respiratory infections has yet to be accounted for. 
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In 2014, Hu et al. studied the genetic diversity of the HCoV-OC43 circulating in Beijing, China [50]. 
The authors performed partial sequencing of the S1 and N genes (24,228–24,785 and 30,022–30,580 
for S1 and N respectively, using the HCoV-OC43 sequence associated with the accession number 
NC_005147 as reference) of 50 HCoV-OC43s detected in the respiratory samples, all taken in 2012. 
They included the sequences published by Lau et al. in their analysis in 2011, and used the 
nomenclature established by these same authors to identify various clusters obtained [33,50].  
In addition to the A and B clusters, they identified 4 other groups, designated UNT1, UNT(B), 
UNT(C/D), and (C/D), respectively. Several clusters were found to correspond to those previously 
described by Lau et al. in 2011 [33]. The UNT(B) cluster or “Untyped B” is a group close to the B 
cluster. The C/D cluster corresponds to the C cluster, named “C/D”, due to the presence of the HK04_02 
strain defined by Lau et al. as a genotype D, referring to a recombination virus belonging to the B cluster 
on the nsp12 sequence and to the C cluster on the S and N sequences [33]. The UNT(C/D) cluster or 
“Untyped (C/D)” corresponds to a group close to the preceding cluster. Finally, the UNT1 cluster or 
“Untyped 1”, which is close to the BCoV sequences included in this analysis, might correspond to the 
E cluster describe in the current study. In the report by Hu et al. (2014), the UNT1 cluster includes only 
five HCoV-OC43s (accession numbers Z32769, HC734573, CQ772300, DD266155, and Z32768) [50]. 
We have verified that they all have the characteristic nucleotide deletion of 12 nucleotides. This very 
recent report supports the results determined in the current study in that they both demonstrate a high 
genetic diversity of circulating HCoV-OC43s. 
The present study highlights the difficulty of investigating intraspecific genetic variability of 
HCoV-OC43s, though the analysis of partial viral genomes (complete genes) allows the description of 
clear recombination patterns. Nevertheless, due to the high evolutionary potential of HCoV-OC43, 
analyzing complete genomes would reveal a more detailed and perhaps more complex recombination 
pattern. In addition, the data reported and analyzed here illustrate the dynamic diversification of  
HCoV-OC43 following its emergence in human. This remarkable diversification contrasts with the 
relative stability of BCoV in cattle (unpublished data). The present study therefore draws attention to 
the importance of increasing our knowledge of the evolution dynamism of coronavirus in combating 
the permanent emergence risk that they pose in the human population, evidenced by the SARS 
pandemic of 2002–2003 and the recently identified MERS-coronavirus in the Middle-East. 
4. Materials and Methods 
4.1. Clinical Samples and Positive Control 
Fifteen human respiratory specimens (upper and lower) positive for HCoV-OC43 using molecular 
detection, sampled from 2001 to 2013 (one to two for each year) were chosen among the specimens 
available at the virology department of the University Hospital of Caen. These specimens were 
sampled from patients suffering from acute upper or lower respiratory diseases, and were sent to our 
laboratory for a viral diagnosis. The detection of HCoV-OC43 was performed using an in-house real-time 
quantitative RT-PCR, for which the original primers may be found in Table 4. Clinical signs, age, and sex 
of patients were investigated and compiled in Table 3. We also used a culture supernatant of the 
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prototype strains VR759 as reference and for validation of our method. This strain was obtained from 
the ATCC and maintained in HRT-18 cells. 
Table 4. Primer and probes used for RT-PCR and full sequencing of nsp12, S, and N genes 
of 15 HCoV-OC43s, and the prototype strain VR759. 
Real-Time RT-PCR 
Primer or  
Probe Name 
Polarity Primer/Probe Sequences (5'-3') 
Gene 
Target 
Location (5'-3') Reference 
LOC1 fwd GTGGTTTTGCTGTTTATGTTAAGT N 28991-29014 this study 
LOC2 rev AGATATTATTTCTCAACAATGCGGT N 29092-29068 this study 
SLOC fwd HEX-AATTACCGACTGCCATCAACCCAAA-BHQ1 N 29026-29050 this study 
RT-PCR and sequencing 
Primer name Polarity Primer sequences (5'-3') 
Gene 
target 
Location (5'-3') Reference 
OC43_P_13158F fwd TTGTGCAAATTACGCGGCAA RdRp 13171-13190 this study 
OC43_P_13896R rev TTCACCAATTTGTCCGCAAAC RdRp 13907-13889 this study 
OC43_P_13645F fwd GCCACACATTGTACGCAAGG RdRp 13649-13668 this study 
OC43_P_14511R rev CCGCTTGTTATAGCGGCAAC RdRp 14515-14496 this study 
OC43_P1_4375F fwd GTGGATACACATCGTTATCGCTT RdRp 14379-14401 this study 
OC43_P_15253R rev CCTATCGCTTTGCGAACAACA RdRp 15257-15237 this study 
LPW 3064F fwd CTGGGATGATATGTTACGCCG RdRp 15095-15115 Lau et al. 2011 
LPW 2579R rev GTGTGTTGTGAACARAAYTCRTG RdRp 15763-15750 Lau et al. 2011 
OC43_P_15276F fwd TGAGTGATGATGGGGTTGTGT RdRp 15577-15597 this study 
OC43_P_16129R rev TTGAGAAGAGCAGACCACGC RdRp 16133-16114 this study 
OC43_P_15814F fwd AGGAGCTGGATGTTTTGTAGATGA RdRp 15818-15841 this study 
LPW 1127R rev TGCCTTTTGCGTTTCTGC RdRp 16520-16503 Lau et al. 2011 
LPW 1162F fwd CCYRTTTGTRTGTATGATCC S 23500-23520 Lau et al. 2011 
LPW 1166R rev YGCATAAAAAGTACCACC S 24325-24307 Lau et al. 2011 
OC43_S_23506F fwd TGTGTGTATGATCCGCTACCAG S 23507-23528 this study 
OC43_S_24384R rev GTGAAAGYGCCATGCCTAAA S 24391-24372 this study 
LPW 6447F fwd CTTCAAAGAACTATGGCATT S 24198-24217 Lau et al. 2011 
LPW 6548R rev GACTGCAAATAGCCCAAATT S 24917-24898 Lau et al. 2011 
LPW 2095F fwd TGATGCTGCTAAGATATATGG S 24804-24824 Lau et al. 2011 
OC43_S_24569R rev AACCTCAACAAAAATGCCTTGG S 25581-25560 this study 
OC43_S_25372F fwd AGCATTTTTGGGTTGGTCTGC S 25383-25402 this study 
OC43_S_26126R rev AATCACCACAGACAAATGCAGC S 26137-26116 this study 
OC43_S_25882F fwd AGGTAGTGGTTACTGTGTGGA S 25893-25913 this study 
LPW 1178R rev GACACCAAGMCCATTAAT S 26652_26635 Lau et al. 2011 
OC43_S_26406F fwd TGATGTCGGTTTTTGTTGAGGC S 26418-26438 this study 
OC43_S_27152R rev CAGACCGGGACTAACCTTCG S 27162-27143 this study 
OC43_S_26971F fwd TGCAGCACAAGCTATGGAGA S 26982-27001 this study 
LPW 1275F fwd TRAAATGGCCTTGGTATGT S 27548-27566 Lau et al. 2011 
LPW 1189R rev TKWMWAGGAACTCTACAATA S 27942-27923 Lau et al. 2011 
OC43_N_28778F fwd TGTTAGGCCGATAATTGAGGACT N 28803-28825 this study 
OC43_N_28728F fwd AACCCAGAAACAAACACY N 28753-28769 this study 
OC43_N_29546R rev GCGGTCCTGTTCCCAGATAG N 29500-29481 this study 
OC43_N_29232F fwd CAGCAACCATCAGGAGGGAA N 29257-29276 this study 
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Table 4. Cont. 
RT-PCR and sequencing 
Primer Name Polarity Primer Sequences (5'-3') Gene Target Location (5'-3') Reference 
OC43_N_30104R rev AAACATCCTTCTGGGGCTG N 30148-30130 this study 
OC43_N_29158F fwd CCGATCAGTCCGACCAGTTT N 29183-29202 this study 
OC43_N_30084R rev TCTGCACTTTGGCCAACTCT N 30109-30090 this study 
OC43_Nd_29879F fwd GAATAARCCCCGCCAGA N 29904-29920 this study 
OC43_N_30656R rev CATGCTGGCTCTTTCCCTTG N 30675-30655 this study 
LPW 1195F fwd GAGAGGCCCTAATCAGAA N 29967-29984 Lau et al. 2011 
OC43_N_30690R rev TTAACTTCATTCATTTACTA N 30715-30696 this study 
4.2. RNA Extraction and Quantitative RT-PCR 
Total nucleic acids of 300 μL of clinical specimens and VR759 cultures supernatant were extracted 
using the QiAsymphony automate and the QIAsynphony virus/bacteria kit (Qiagen, Holden, 
Germany), following instructions of manufacturer. 
4.3. Sequencing of the 3 Complete Genes Nsp12, S and N 
To determine the genomic sequence of nsp12, S, and N genes, a set of 17 overlapping RT-PCR 
products, from 600 to 900 nucleotides, were generated. These RT-PCR products encompassed the  
entire three genes. Twelve primers were used to amplify and sequence the nsp12 gene, composed of  
2783 nucleotides and located from nucleotides 13,317 to 16,099 (reference to VR759, NC005147). 
Eighteen primers were used to amplify and sequence the S gene composed of 4062 nucleotides. This gene 
is located in the last third of the HCoV-OC43 genome, between bases 23,644 and 27,729 (reference to 
HCoV-OC43 VR759, NC005147). Six primers were used to amplify and sequence the N gene composed of 
1347 nucleotides and located at the 3’ end of the HCoV-OC43 genome, from nucleotide 29,104 to 30,450 
(reference to HCoV-OC43 VR759, NC005147). For both RT-PCR and sequencing reactions, primers were 
selected in conserved domains from an alignment of the previously published HCoV-OC43. Some of the 
selected primers were published by Lau in 2011, but others were designed using Primer-Blast software 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) [33]. All of them were tested in silico and in vitro with the 
VR759 prototype strain to test their efficacy. In vitro experimentations have also been conducted using the 
VR759 strain to test the primer abilities to provide us with quality sequencing products. Alternative original 
primers were used for HCoV-OC43/FRA_EPI/Caen/2001/02, HCoV-OC43/FRA_EPI/Caen/2002/04, 
HCoV-OC43/FRA_EPI/Caen/2007/09, HCoV-OC43/FRA_EPI/Caen/2001/01, and HCoV-OC43/FRA_EPI/ 
Caen/2002/03. The sequences of the 42 primers used for RT-PCR and sequencing are given in Table 4, 
associated with the corresponding targeted gene and with the fragment size. RT-PCR reactions were 
performed using OneStep RT-PCR System (Qiagen, Holden, Germany), from 2.5 μL of nucleic acid in 
a final volume of 25 μL. The same primers were used to perform the complete bidirectional 
sequencing of the RT-PCR products, with a Sanger derived method. 2.5 μL of each RT-PCR product 
were first purified by adding 1 μL of ExoSAP-IT (USB corporation, Cleveland, OH, USA), and by heating 
it at 37 °C for 15 min, followed by 15 min at 80 °C to disable enzymatic activities. Two sequencing 
reactions were performed for each RT-PCR product with either a forward or a reverse primer. 1 to 2 μL of 
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purified RT-PCR product were used in a final volume of 10 μL of reaction mixture, made up with the 
BigDye terminator cycle sequencing kit, version 1.1 (Applied Biosystems, Foster City, CA, USA), in 
addition to 1 μL of one of the corresponding primers. The cycling parameters for the sequencing  
RT-PCR were 96 °C for 1 min, followed by 30 cycles of 96 °C for 10 s, 60 °C for 5 s, and 60 °C for 4 min. 
The analysis of labelled products was performed by the capillary electrophoresis ABI Prism 3500 
genetic analyzer (Applied Biosystems, Foster City, CA, USA), by the molecular genetics laboratory of 
the University Hospital of Caen. In this study, the term of molecular isolate was use to designate the 
sequence of HCoV-OC43 detected directly from clinical sample. 
4.4. Bioinformatic Analysis 
Sequences were assembled in contigs corresponding to the entire nsp12, S or N genes with 
CodonCode Aligner Software, version 5.0.1 (CodonCode corporation, Centerville, MA, USA). 
Multiple sequence alignment and phylogenetic analysis were performed using MEGA software, 
version 6.06 (http://www.megasoftware.net). Twenty-one sequences available in GenBank were added 
to the alignment, including HCoV-OC43s HKU4_01 and HKU4_02 from Hong-Kong [33];  
HCoV-OC43s BE03 and BE04 from Belgium [34]; HCoV-OC43s OC43/human/USA/851-15/1985, 
OC43/human/USA/007-11/2000, OC43/human/USA/925-1/1992, OC43/human/USA/8912-37/1989, 
OC43/human/USA/953-23/1995, OC43/human/USA/951-18/1995, OC43/human/USA/872-5/1987, 
OC43/human/USA/901-54/1990, OC43/human/USA/931-85/1993, OC43/human/USA/911-58/1991, 
OC43/human/USA/008-5/2000, OC43/human/USA/832-27/1983, OC43/human/USA/965-6/1996 and 
OC43/human/USA/971-5/1997 from the USA, recently submitted by Town et al.; and BCoV 
Kakewaga, Mebus, and Quebec to root the trees [36,38,51]. The accession numbers corresponding to 
these sequences are given in Table 3. Phylogenetic trees were constructed using the method of 
neighbor joining, with the substitution model of Kimura-2, implemented in MEGA6 [41,52]. These 
trees were used to perform the comparative analysis of our results with those of Lau et al in 2011 [33]. 
In order to support neighbour joining trees with a probabilistic method and to estimate divergence time 
between groups and subgroups, trees of S and N genes were also inferred using the same sequences 
and a Bayesian Markov Chain Monte Carlo method, implemented in the BEAST package, version 
1.8.1 [42,53]. Inferences were calculated with the one parametric coalescent model with a constant 
size, under the TN93+G substitution model according to Bayesian Information Criterion (BIC) and 
Akaike Information Criterion (AIC) values of a model test carried out on MEGA6 software. The 
tMRCA was estimated using a relaxed molecular clock with an uncorrelated lognormal distribution. 
The length of MCMC was fixed at 3 × 10−8 states for the both genes. The Tracer software, version 1.5, 
implemented in the BEAST package, was used to assess the fitness of the model used, focusing the 
Effective Sampling Size (ESS) data, after a burning of 10%. The target trees were obtained with the 
maximum credibility clades, with a posterior probability limit of 0.05. The tMRCA age for each 
genotype was compared for S and N genes. 
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